Stereotaxis announced that regulatory submissions were made recently in both Europe and the United States for the MAGiC catheter. These submissions follow successful initial clinical results in an ongoing trial.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on STXS:
- Stereotaxis Reports 2023 Full Year Financial Results
- Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
- STXS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Intermountain Health Extends Leadership in Heart Care with Adoption of Advanced Robotic Technology
- Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
